Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: Effect of ethnicity, cardiovascular disease, and diabetes

Angiology

Volumn 62, Issue 7, 2011, Pages 571-578

  Jaumdally, Rumi J ^a   Lip, Gregory Y H ^a   Varma, Chetan ^a   Blann, Andrew D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

angiopoietin; atorvastatin; diabetes; ethnicity; vascular disease

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PADGEM PROTEIN; TRIACYLGLYCEROL; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG MEGADOSE; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HUMAN; MALE; OUTPATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; THROMBOCYTE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION;

ADULT; AGED; ANGIOGENIC PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CD40 LIGAND; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; P-SELECTIN; PYRROLES; VON WILLEBRAND FACTOR;

EID: 80052764519     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711401904     Document Type: Article

References (44)

1. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004 ; 164 (13). 1427-1436 (Pubitemid 38937854)
2. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005 ; 352 (1). 29-38 (Pubitemid 40075678)
3. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005 ; 352 (14). 1425-1435 (Pubitemid 40471450)
4. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ; 350 (15). 1495-1504 (Pubitemid 38477774)
5. Merten M, Dong JF, Lopez JA, Thiagarajan P. Cholesterol sulfate: a new adhesive molecule for platelets. Circulation. 2001 ; 103 (16). 2032-2034 (Pubitemid 32373002)
6. Notarbartolo A, Davi G, Averna M, et al. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995 ; 15 (2). 247-251
7. Lacoste L, Lam JY, Hung J, Letchacovski G, Solymoss CB, Waters D. Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction. Circulation. 1995 ; 92 (11). 3172-3177
8. Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation. 1999 ; 99 (25). 3227-3233 (Pubitemid 29293431)
9. Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signalling. Circ Res. 2002 ; 90 (6). 737-744 (Pubitemid 34640894)
10. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999 ; 5 (4). 434-438 (Pubitemid 29180584)
11. Toyota E, Matsunaga T, Chilian WM. Myocardial angiogenesis. Mol Cell Biochem. 2004 ; 264 (1-2). 35-44 (Pubitemid 39366103)
12. Jaumdally JR, Varma C, Lip GY. Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?. Expert Opin Pharmacother. 2007 ; 8 (9). 1235-1243 (Pubitemid 47034412)
13. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991 ; 337 (8738). 382-386
14. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004 ; 20 (5). 482-491 (Pubitemid 38501805)
15. Tousoulis D, Bosinakou E, Kotsopoulou M, Antoniades C, Katsi V, Stefanadis C. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina. Int J Cardiol. 2006 ; 106 (3). 333-337 (Pubitemid 41766634)
16. Lim HS, Chong AY, Freestone B, Blann AD, Lip GY. The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease. Diabet Med. 2005 ; 22 (3). 249-255 (Pubitemid 40313849)
17. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J. 2003 ; 326 ( ): 1423. Review
18. Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. 2008 ; 29 (17). 2083-2091
19. Tziomalos K, Athyros VG, Mikhailidis DP. Statin discontinuation: an underestimated risk?. Curr Med Res Opin. 2008 ; 24 (11). 3059-3062
20. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002 ; 23 (23). 1809-1840
21. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1.Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998 ; 15 (7). 539-553 (Pubitemid 28319935)
22. Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GYH. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol. 2002 ; 90 (11). 1258-1260 (Pubitemid 35346888)
23. Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GYH. Plasma angiopoietin-1, angiopoietin-2 and tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest. 2003 ; 33 (10). 883-890 (Pubitemid 37215044)
24. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol. 2004 ; 43 (3). 423-428 (Pubitemid 38167703)
25. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003 ; 52 (5). 1210-1214 (Pubitemid 36523358)
26. Barnett AH, Dixon AN, Bellary S, et al. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia. 2006 ; 49 (10). 2234-2246 (Pubitemid 44359083)
27. Razak F, Anand SS, Shannon H, Vuksan V, Davis B, Jacobs R, Teo KK, McQueen M, Yusuf S. Defining obesity cut points in a multiethnic population. Circulation. 2007 ; 115 (16). 2111-2118 (Pubitemid 46659062)
28. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost. 2006 ; 95 (1). 49-55
29. Dechanet J, Grosset C, Taupin JL, et al. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol. 1997 ; 159 (11). 5640-5607
30. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995 ; 332 (10). 635-641
31. Schonbeck U, Varo N, Libby P. Soluble CD40L and cardiovascular risk in women. Circulation. 2001 ; 104 (19). 2266-2268 (Pubitemid 33049505)
32. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 2003 ; 24 (24). 2166-2179 (Pubitemid 37522669)
33. Kappelmayer J, Nagy B, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med. 2004 ; 42 (5). 475-486 (Pubitemid 38779747)
34. Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporarily limited by coexpressed CD40. Blood. 2001 ; 98 (4). 1047-1054
35. Kinlay S, Schwartz GG, Olsson AG, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 ; 110 (4). 386-391 (Pubitemid 38993846)
36. Yan JC, Zhu J, Gao L, Wu ZG, Kong XT, Zong RQ, Zhan LZ. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clin Chim Acta. 2004 ; 343 (1-2). 155-159 (Pubitemid 38534509)
37. Couffinhal T, Kearney M, Witzenbichler B, et al. Vascular endothelial growth factor (VEGF) in normal and atherosclerotic human arteries. Am J Pathol. 1997 ; 150 (5). 1673-1685 (Pubitemid 27193815)
38. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006 ; 27 (12). 552-558 (Pubitemid 44780853)
39. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996 ; 87 (7). 1171-1180 (Pubitemid 27010101)
40. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005 ; 118 (pt 4). 771-780 (Pubitemid 40372585)
41. Daly C, Pasnikowski E, Burova E, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A. 2006 ; 103 (42). 15491-1546
42. Bielecka-Dabrowa A, Goch JH, Mikhailidis DP, Rysz J, Maciejewski M, Banach M. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. Med Sci Monit. 2009 ; 15 (12). MS12 - MS23
43. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial Weibel-Palade bodies. Blood. 2004 ; 103 (11). 4150-4156 (Pubitemid 38685356)
44. Tziomalos K, Weerasinghe CN, Mikhailidis DP, Seifalian AM. Vascular risk factors in South Asians. Int J Cardiol. 2008 ; 128 (1). 5-16